CPA Congratulates President-Elect Donald Trump on Victory
CPA will be working closely with President-Elect Trump’s team to craft policies that will make a lasting impact on U.S. trade and industrial policy.
Drug Shortages Increase Odds Of Patient Death; More Than Half of Drugs In Short Supply For Over 12 Months.
Drug shortages are becoming commonplace in the U.S. Data from a new pharmaceutical industry tracking firm, Qyobo, shows hundreds of drugs are still in short supply – some well over a year — and our dependence on imports grows, including from labs on the receiving end of lackluster FDA inspections.
How to Address America’s Historic Drug Shortage Crisis
The United States is facing an unprecedented drug shortage, with a record 323 active drug shortages at the start of 2024 — the highest number since 2001.
Rx Import Alert: CVS Branded Generic Drugs Singled Out In Bloomberg Report For Most Recalls
The foreign labs in China and India that make the branded drugs for CVS pharmacies nationwide are coming under increased scrutiny for unsafe manufacturing practices.
Monthly Trade Deficit Suddenly Rises 8.7%, Surpassing Three-Month Trend Line
The monthly goods and services trade deficit between the U.S. and the rest of the world has skyrocketed by a whopping 8.7% to $74.6 billion in April, putting the month well above the three month trend line.
FDA Official Laments To Congress That Drug Recall Decisions Rely On Foreign Labs
When drugs are pulled from pharmacy shelves, it’s somewhat of a well-kept secret that it is the pharmaceutical company that voluntarily warns buyers of the potential harm from the defect.
Indian Pharmaceutical Company Zydus Lifesciences Fails 10 FDA Requirements
Generic drug exporter Zydus Lifesciences received poor marks again in April following a Food and Drug Administration inspection of its lab in Vadodara, a city in Gujarat state on India’s western coast.
Veterans Hospitals Ban Use of China-Made Syringes Due to Safety Issues
The Veterans Health Administration (VHA) banned the use of plastic syringes made in China on April 23 due to safety concerns, ahead of a warning letter dated April 24 to Ohio-based importer Cardinal Health by the Food and Drug Administration.
Katherine Tai Gets an Earful from Ways & Means on Mexico, De Minimis, GSP Renewal, Agriculture Deficits, and Generic Drug Imports.
USTR Katherine Tai sat for a two hours-plus hearing with the House Ways and Means Committee on Tuesday to discuss trade matters and was met early on by some staunch criticism.
America’s Life-Threatening Drug Shortages Reach Record Highs
Despite spending over $600 billion on prescription drugs, the number of drugs in shortage rose to a near-record total of 301 active medication shortages at the end of 2023.
